Amylyx Pharmaceuticals, Inc. Quarterly Assets in USD from Q4 2021 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Amylyx Pharmaceuticals, Inc. quarterly Assets history and growth rate from Q4 2021 to Q3 2024.
Amylyx Pharmaceuticals, Inc. Assets for the quarter ending September 30, 2024 was $251M, a 46.3% decline year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$251M	-$216M	-46.3%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$332M	-$121M	-26.8%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$417M	+$9.5M	+2.33%	Mar 31, 2024	10-Q	2024-05-09
Q4 2023	$517M	+$126M	+32.2%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$467M	+$285M	+157%	Sep 30, 2023	10-Q	2023-11-09
Q2 2023	$454M	+$228M	+101%	Jun 30, 2023	10-Q	2023-08-10
Q1 2023	$408M	+$134M	+48.7%	Mar 31, 2023	10-Q	2023-05-11
Q4 2022	$391M	+$286M	+271%	Dec 31, 2022	10-K	2024-02-22
Q3 2022	$181M			Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$225M			Jun 30, 2022	10-Q	2022-08-11
Q1 2022	$274M			Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$106M			Dec 31, 2021	10-K	2023-03-13

* An asterisk sign (*) next to the value indicates that the value is likely invalid.